HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

1-[(2R,4R,5S)-4-Azido-5-(hydroxymethyl)oxolan-2-YL]-5-methyl-pyrimidine-2,4-dione

HCID 5726
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
30516-87-1
Standard SMILES
Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)[nH]c1=O
InChIKey
HBOMLICNUCNMMY-UHFFFAOYSA-N
Molecular formula
C10H13N5O4
Average molar mass
267.24 g/mol

Overview

See also: Zidovudine (annotation moved to).

Names & identifiers

Preferred name
1-[(2R,4R,5S)-4-Azido-5-(hydroxymethyl)oxolan-2-YL]-5-methyl-pyrimidine-2,4-dione
IUPAC
1-[4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
English name
Zidovudine
Molecular formula
C10H13N5O5
Molecular weight
283.24

Names & synonyms

Azidothymidine (AZT)S25791-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione1-[4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione1-[(2R,4R,5S)-4-AZIDO-5-(HYDROXYMETHYL)OXOLAN-2-YL]-5-METHYL-PYRIMIDINE-2,4-DIONE399024-19-2AzitidinTimazidZidovudine, AZTRecemic Zidovudine1-(4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dioneThymidine, 8CI,
Show more names
AZTAZIDOTHYMIDINE1-((2R,4S,5S)-4-azido-5-(hydroxyMethyl)tetrahydrofuran-2-yl)-5-MethylpyriMidine-2,4(1H,3H)-dioneretrovirZDVAzitidineAZT (pharmaceutical)ZVDfuseng
Trizivir (Salt/Mix)3-Azido-3-deoxythymidineSCHEMBL13609910component of Combivir (Salt/Mix)HBOMLICNUCNMMY-UHFFFAOYSA-NHMS3369K15HMS3656A20HMS5081B07

Database identifiers

CAS
30516-87-1
PubChem CID
5726

Properties

Computed structural properties

XLogP
0
Topological polar surface area
93.2 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
6
Rotatable bonds
3
Heavy atoms
19
Formal charge
0
Complexity
484

Experimental & physicochemical properties

DrugsPharmaceuticals

Physicochemical properties

Melting point
113 · 113-115 °C (lit.)
Boiling point
410.43 °C · 410.43°C (rough estimate)
alpha
25 · D25 +99° (c = 0.5 in water)
Density
1.3382 · 1.3382 (rough estimate)
refractive index
47 ° · 47 ° (C=1, H2O)
Flash point
9 ℃ · 9℃
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: 50 mg/mL
form
Powder
pka
9.53 · pKa 9.53(H2O t = 25.0±0.1 I = 0.00) (Uncertain)
color
White to Off-white
Water Solubility
1 · 1-5 g/100 mL at 17 ºC
Sensitive
Light Sensitive & Hygroscopic
Merck
14 · 14,10123
BRN
3595791 · 3595791
BCS Class
1 · 1,3
Stability
2 years · Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
InChI
1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1
InChIKey
HBOMLICNUCNMMY-BWZBUEFSSA-N
SMILES
CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
Toxicology and Carcinogenesis
Toxicology and Carcinogenesis Studies of AZT (CASRN 30516-87-1) and AZT/ a-Interferon A/D in B6C3F1 Mice (Gavage Studies)Toxicology and Carcinogenesis Studies of Transplacental AZT (CASRN 30516-87-1) in Swiss (CD-1®) Mice (in utero Studies)Toxicology and Carcinogenesis Studies of Mixtures of 3'-Azido-3'-Deoxythymidine (AZT), Lamivudine (3TC), Nevirapine (NVP), and Nelfinavir Mesylate (NFV) (CASRNs 30516-87-1, 134678-17-4, 129618-40-2, 159989-65-8) in B6C3F1 Mice (Transplacental Exposure Studies)
CAS DataBase Reference
30516 · 30516-87-1(CAS DataBase Reference)
FDA UNII
4 B9XT59T7S · 4B9XT59T7S
NCI Dictionary of Cancer Terms
AZT; zidovudine
NCI Drug Dictionary
Retrovir
ATC code
5 AF01 · J05AF01
Proposition 65 List
Zidovudine (AZT)
IARC
2 B · 2B (Vol. 76) 2000
EPA Substance Registry System
3 · Thymidine, 3'-azido-3'-deoxy- (30516-87-1)
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Protein binding
34 · 34-38%
Excreted unchanged in urine
8 · 8-25%
Volume of distribution
1.6 · 1.6(L/kg)
Biological half-life
1.1 · 1.1 / 1. 4-3
Symbol(GHS)
2 · GHS02,GHS06,GHS08
Signal word
Danger
Hazard statements
303 · H303-H225-H301+H311+H331-H370-H351
Precautionary statements
210 · P210-P260-P280-P301+P310-P311-P281-P501a-P201-P202-P308+P313-P405-P501
PPE
3 · Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
Hazard Codes
Xn
Risk Statements
40 · 40-36/37/38-20/21/22
Safety Statements
36 · 36/37/39-45-36-26
RIDADR
1230 · UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany
3 · 3
RTECS
2072000 · XP2072000
F
10 · 10
Hazard Note
Harmful
HS Code
29349990 · 29349990
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
2 Muta · Carc. 2Muta. 2
Hazardous Substances Data
30516 · 30516-87-1(Hazardous Substances Data)
Toxicity
50 in · LD50 in male, female mice, male, female rats (mg/kg): 3568, 3062, 3084, 3683 orally; >750 i.v. (all species) (Ayers)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

F
10
PPE
Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
wgk
3
rtecs
XP2072000
ridadr
UN1230 - class 3 - PG 2 - Methanol, solution
hs_code
29349990
Toxicity
LD50 in male, female mice, male, female rats (mg/kg): 3568, 3062, 3084, 3683 orally; >750 i.v. (all species) (Ayers)
risk_code
40-36/37/38-20/21/22
Signal word
Danger
Symbol(GHS)
GHS02,GHS06,GHS08
hazard_code
Xn
hazard_note
Harmful
safety_code
36/37/39-45-36-26
Storage Class
11 - Combustible Solids
Hazard statements
H303-H225-H301+H311+H331-H370-H351
Hazard Classifications
Carc. 2Muta. 2
Precautionary statements
P210-P260-P280-P301+P310-P311-P281-P501a-P201-P202-P308+P313-P405-P501
Hazardous Substances Data
30516-87-1(Hazardous Substances Data)

Chemistry & industry

Applications · 6 items

DescriptionZidovudine, also known as azidothymidine (AZT), is an antiviral agent acting via reverse transcnptase inhibition. It was first launched in the U.K. and subsequently introduced in over a dozen countries for the management of severe manifestations of HIV infection. In patients with AIDS and ARC, zidovudine reduces the risk of opportunistic infections and prolongs survival time. In symptom-free patients it shows promise in halting further immunological deterioration.

UsesA potent and selective inhibitor of HIV-1 replication

UsesZidovudine is an antiretroviral drug that is clinically active against HIV-1 and is intended to treat HIV-infected patients. Zidovudine is an analog of thymidine that inhibits replication of the AIDS virus. It also turned into mono-, di-, and triphosphates by the same cellular enzymes that catalyze phosphorylation of thymidine and thymidine nucleosides. Zidovudine-triphosphate is then included in the terminal fragment of the growing chain of viral DNA by viral reverse transcriptase, thus causing the viral DNA chain to break apart in cells infected with the virus. Zidovudine has been authorized for treating patients with AIDS. It significantly prolongs the life of the patient, although it has a number of toxic effects. Synonyms of this drug are azidothymidine and retrovir.

General DescriptionSlightly off-white odorless powdery solid.

General DescriptionZidovudine, 3'-azido-3'-deoxythymidine or AZT, is ananalog of thymidine that possesses antiviral activityagainst HIV-1, HIV-2, HTLV-1, and several other retroviruses.This nucleoside was synthesized in 1978 by Linand Prusoff as an intermediate in the preparation ofamino acid analogs of thymidine. A screening program directedtoward the identification of agents potentially effectivefor the treatment of patients with AIDS led to the discoveryof its unique antiviral properties 7 years later.Zidovudine is recommended for the management of adultpatients with symptomatic HIV infection (AIDS or ARC)who have a history of confirmed Pneumocystis carinii pneumoniaor an absolute CD4+(T4 or TH cell) lymphocytecount below 200/mm3 before therapy. The hematologicaltoxicity of the drug precludes its use in asymptomatic patients.Anemia and granulocytopenia are the most commontoxic effects associated with AZT.

General DescriptionZidovudine, or 3u-azido-3udeoxythymidine, formerly known as azidothymidine (AZT; BW A509U), is an analog of the nucleoside thymidine. It is an inhibitor of the human immunodeficiency virus (HIV)-encoded enzyme reverse transcriptase. It was the first antiretroviral compound to be licenced for the treatment of people infected with HIV. The compound was synthesized much earlier, however, by Horwitz and colleagues and subsequently used in anticancer research. Zidovudine was developed by Burroughs Wellcome and is now marketed by GlaxoSmithKline under the trade name of Retrovir. Zidovudine is also available in fixed-dose cominations with other nucleoside analog reverse transcriptase inhibitors as Combivir (zidovudine with lamivudine) and Trizivir (zidovudine with lamivudine and abacavir). Generic forms of the drug have been produced by a number of companies and include AVIRO-Z (Ranbaxy Laboratories Ltd) and Zidovir (Cipla Ltd). There are also a number of generic fixed-dose products including zidovudine with lamivudine (e.g. Duovir; Cipla Ltd). Zidovudine is indicated for the treatment and prevention of HIV infection, generally given in combination with other antiretroviral agents.

Upstream & downstream products

Upstream raw materials

Sodium azideThymidineDiethyl azodicarboxylate4-Methoxybenzoic acidMethanol solution of sodium methoxideEthyl acetateTriphenylphosphineFormamide2,3'-Anhydrothymidine5'-O-Benzoyl-3'-azido-3'-deoxythymidine3-Azido-3-deoxy-5-O-triphenylmethylthymidine3'-Bromo-3'-deoxythymidine1-[(2R,4S,5S)-4-Amino-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione

Downstream products

3'-Azido-2',3'-dideoxyadenosine
Additional notes · 1 item

DefinitionChEBI: Zidovudine is a pyrimidine 2',3'-dideoxyribonucleoside compound having a 3'-azido substituent and thymine as the nucleobase. It has a role as an antimetabolite, an antiviral drug and a HIV-1 reverse transcriptase inhibitor. It is an azide and a pyrimidine 2',3'-dideoxyribonucleoside.

Related reactions

13 records
New reaction record
HRID 188996 reaction equation
HRID 188996As productAs reactant
HRID 298897 reaction equation
HRID 298897As reactant
HRID 677667 reaction equation
HRID 677667As reactant
HRID 822869 reaction equation
HRID 822869As reactant
HRID 956647 reaction equation
HRID 956647As reactant
HRID 1139146 reaction equation
HRID 1139146As reactant
HRID 1150685 reaction equation
HRID 1150685As reactant
HRID 1151961 reaction equation
HRID 1151961As reactant
PreviousPage 1 of 2

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes